| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +530,038 | 51% | $37.71 | +$19,988,986 |
| Sells | 16 | -500,773 | 49% | $40.89 | -$20,477,135 |
| Net | -15 | +29,265 | 2.8% | -$488,149 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Public Equities L.P. Invus | 10%+ Owner | $385,262,708 | 10 Dec 2024 | ||
| Samsara BioCapital GP, LLC | 10%+ Owner | $108,133,716 | 16 Oct 2023 | ||
| L.L.C. Siren | 10%+ Owner | $101,166,050 | 25 Jul 2024 | ||
| David Hallal | Chief Executive Officer, Director | $81,659,710 | -$2,453,115 | -2.9% | 09 Feb 2026 |
| Invus Global Management, LLC | 10%+ Owner | $79,563,845 | 11 Dec 2025 | ||
| Kristina Burow | Director | $74,283,952 | -$160,511 | -0.22% | 29 May 2025 |
| Srinivas Akkaraju | Director | $69,429,463 | +$19,988,986 | +40% | 07 Oct 2025 |
| Akshay Vaishnaw | President of R&D, Director | $27,999,845 | -$1,073,315 | -3.7% | 09 Feb 2026 |
| Keith Woods | Chief Operating Officer | $27,454,779 | -$715,054 | -2.5% | 09 Feb 2026 |
| Vikas Sinha | Chief Financial Officer | $27,454,386 | -$715,439 | -2.5% | 09 Feb 2026 |
| Backstrom Jay T. | CHIEF EXECUTIVE OFFICER, Director | $16,062,247 | 10 Mar 2025 | ||
| Junlin Ho | General Counsel | $11,238,654 | -$1,040,428 | -8.5% | 17 Feb 2026 |
| Caryn Parlavecchio | Chro | $7,867,313 | -$979,776 | -11% | 17 Feb 2026 |
| Nagesh K. Mahanthappa | Interim CEO and President | $7,653,597 | 16 Jun 2022 | ||
| Jing L. Marantz | Chief Medical Officer | $5,863,111 | -$451,299 | -7.1% | 17 Feb 2026 |
| Mo Qatanani | Chief Scientific Officer | $4,772,613 | -$9,758,933 | -67% | 23 Feb 2026 |
| YUNG H. CHYUNG | Chief Medical Officer | $4,117,505 | 14 Feb 2022 | ||
| Edward H. Myles | Coo & Cfo | $3,882,600 | 10 Mar 2025 | ||
| Erin Moore | Interim PFO and PAO | $2,735,994 | -$449,237 | -14% | 24 Mar 2025 |
| Tracey Sacco | Chief Commercial Officer | $2,402,548 | -$379,145 | -14% | 25 Apr 2025 |
| Gregory John Carven | Chief Scientific Officer | $2,042,187 | 16 Jun 2022 | ||
| Michael Gilman | Director | $1,647,341 | -$100,304 | -5.7% | 29 May 2025 |
| Katie Peng | Director | $1,468,828 | -$208,593 | -12% | 16 Dec 2025 |
| JEFFREY S. FLIER | Director | $852,559 | -$1,650,994 | -66% | 16 Jul 2025 |
| Amir Nashat | Director | $608,302 | 09 May 2024 | ||
| Joshua Reed | Director | $472,644 | -$160,463 | -25% | 29 May 2025 |
| Richard Brudnick | Director | $451,756 | -$180,531 | -29% | 29 May 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|